These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 12110174)

  • 21. AlphaIIb integrin expression during development of the murine hemopoietic system.
    Corbel C; Salaün J
    Dev Biol; 2002 Mar; 243(2):301-11. PubMed ID: 11884039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The earliest thymic progenitors for T cells possess myeloid lineage potential.
    Bell JJ; Bhandoola A
    Nature; 2008 Apr; 452(7188):764-7. PubMed ID: 18401411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pbx1 restrains myeloid maturation while preserving lymphoid potential in hematopoietic progenitors.
    Ficara F; Crisafulli L; Lin C; Iwasaki M; Smith KS; Zammataro L; Cleary ML
    J Cell Sci; 2013 Jul; 126(Pt 14):3181-91. PubMed ID: 23660001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A close developmental relationship between the lymphoid and myeloid lineages.
    Kawamoto H
    Trends Immunol; 2006 Apr; 27(4):169-75. PubMed ID: 16515884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inducible Fli-1 gene deletion in adult mice modifies several myeloid lineage commitment decisions and accelerates proliferation arrest and terminal erythrocytic differentiation.
    Starck J; Weiss-Gayet M; Gonnet C; Guyot B; Vicat JM; Morlé F
    Blood; 2010 Dec; 116(23):4795-805. PubMed ID: 20733157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antagonistic effect of CCAAT enhancer-binding protein-alpha and Pax5 in myeloid or lymphoid lineage choice in common lymphoid progenitors.
    Hsu CL; King-Fleischman AG; Lai AY; Matsumoto Y; Weissman IL; Kondo M
    Proc Natl Acad Sci U S A; 2006 Jan; 103(3):672-7. PubMed ID: 16407117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL-3 induces inhibitor of DNA-binding protein-1 in hemopoietic progenitor cells and promotes myeloid cell development.
    Leeanansaksiri W; Wang H; Gooya JM; Renn K; Abshari M; Tsai S; Keller JR
    J Immunol; 2005 Jun; 174(11):7014-21. PubMed ID: 15905544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. E2F4 modulates differentiation and gene expression in hematopoietic progenitor cells during commitment to the lymphoid lineage.
    Enos ME; Bancos SA; Bushnell T; Crispe IN
    J Immunol; 2008 Mar; 180(6):3699-707. PubMed ID: 18322175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Direct evidence for the commitment of hematopoietic stem cells to T, B and myeloid lineages in murine fetal liver.
    Kawamoto H; Ohmura K; Katsura Y
    Int Immunol; 1997 Jul; 9(7):1011-9. PubMed ID: 9237110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Hedgehog receptor Patched controls lymphoid lineage commitment.
    Uhmann A; Dittmann K; Nitzki F; Dressel R; Koleva M; Frommhold A; Zibat A; Binder C; Adham I; Nitsche M; Heller T; Armstrong V; Schulz-Schaeffer W; Wienands J; Hahn H
    Blood; 2007 Sep; 110(6):1814-23. PubMed ID: 17536012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isolation of MYADM, a novel hematopoietic-associated marker gene expressed in multipotent progenitor cells and up-regulated during myeloid differentiation.
    Pettersson M; Dannaeus K; Nilsson K; Jönsson JI
    J Leukoc Biol; 2000 Mar; 67(3):423-31. PubMed ID: 10733104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of Flt3⁺CD150⁻ myeloid progenitors in adult mouse bone marrow that harbor T lymphoid developmental potential.
    Chi AW; Chavez A; Xu L; Weber BN; Shestova O; Schaffer A; Wertheim G; Pear WS; Izon D; Bhandoola A
    Blood; 2011 Sep; 118(10):2723-32. PubMed ID: 21791413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emergence of T, B, and myeloid lineage-committed as well as multipotent hemopoietic progenitors in the aorta-gonad-mesonephros region of day 10 fetuses of the mouse.
    Ohmura K; Kawamoto H; Fujimoto S; Ozaki S; Nakao K; Katsura Y
    J Immunol; 1999 Nov; 163(9):4788-95. PubMed ID: 10528178
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SCL expression at critical points in human hematopoietic lineage commitment.
    Zhang Y; Payne KJ; Zhu Y; Price MA; Parrish YK; Zielinska E; Barsky LW; Crooks GM
    Stem Cells; 2005; 23(6):852-60. PubMed ID: 15917481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of the chromatin remodeler Mi-2beta in hematopoietic stem cell self-renewal and multilineage differentiation.
    Yoshida T; Hazan I; Zhang J; Ng SY; Naito T; Snippert HJ; Heller EJ; Qi X; Lawton LN; Williams CJ; Georgopoulos K
    Genes Dev; 2008 May; 22(9):1174-89. PubMed ID: 18451107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T-, B- and NK-lymphoid, but not myeloid cells arise from human CD34(+)CD38(-)CD7(+) common lymphoid progenitors expressing lymphoid-specific genes.
    Hoebeke I; De Smedt M; Stolz F; Pike-Overzet K; Staal FJ; Plum J; Leclercq G
    Leukemia; 2007 Feb; 21(2):311-9. PubMed ID: 17170726
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multilineage priming of enhancer repertoires precedes commitment to the B and myeloid cell lineages in hematopoietic progenitors.
    Mercer EM; Lin YC; Benner C; Jhunjhunwala S; Dutkowski J; Flores M; Sigvardsson M; Ideker T; Glass CK; Murre C
    Immunity; 2011 Sep; 35(3):413-25. PubMed ID: 21903424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myeloid lineage commitment from the hematopoietic stem cell.
    Iwasaki H; Akashi K
    Immunity; 2007 Jun; 26(6):726-40. PubMed ID: 17582345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of MS4A3 as a reliable marker for early myeloid differentiation in human hematopoiesis.
    Ishibashi T; Yokota T; Satoh Y; Ichii M; Sudo T; Doi Y; Ueda T; Nagate Y; Hamanaka Y; Tanimura A; Ezoe S; Shibayama H; Oritani K; Kanakura Y
    Biochem Biophys Res Commun; 2018 Jan; 495(3):2338-2343. PubMed ID: 29274779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Architectural and functional heterogeneity of hematopoietic stem/progenitor cells in non-del(5q) myelodysplastic syndromes.
    Chesnais V; Arcangeli ML; Delette C; Rousseau A; Guermouche H; Lefevre C; Bondu S; Diop M; Cheok M; Chapuis N; Legros L; Raynaud S; Willems L; Bouscary D; Lauret E; Bernard OA; Kosmider O; Pflumio F; Fontenay M
    Blood; 2017 Jan; 129(4):484-496. PubMed ID: 27856460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.